2022
Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer
Leapman MS, Dinan M, Pasha S, Long J, Washington SL, Ma X, Gross CP. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer. JAMA Oncology 2022, 8: 687-696. PMID: 35238879, PMCID: PMC8895315, DOI: 10.1001/jamaoncol.2021.8116.Peer-Reviewed Original ResearchConceptsProstate magnetic resonance imagingMagnetic resonance imagingPopulation-based cohort studyProstate cancerWhite patientsRacial disparitiesCohort studyMRI useIndividual-level socioeconomic statusEligible male patientsSocioeconomic statusNeighborhood-level socioeconomic statusLocalized prostate cancerProstate cancer diagnosisObserved racial disparitiesProstate magnetic resonanceMediation analysisPathologic factorsMale patientsUS SurveillanceBlack patientsMedicare databaseMAIN OUTCOMEUS adultsNew diagnosis
2007
Myelodysplastic syndromes
Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes. Cancer 2007, 109: 1536-1542. PMID: 17345612, DOI: 10.1002/cncr.22570.Peer-Reviewed Original ResearchConceptsSurvival of patientsOutcome of MDSMyelodysplastic syndromeDescriptive epidemiologic dataHigh incidence rateIncident casesIncidence rateEpidemiologic dataRisk of MDSPopulation-based databaseEnd Results ProgramCancer Reporting SystemPopulation-based cancer reporting systemsPublic-use databaseMDS survivalWorse survivalMale patientsMDS patientsRefractory anemiaResults ProgramClinical subtypesSEER dataSEER programMDS casesPatients